
Trump administration's guidance on emergency care law adds to ‘chaos,' not clarity, in states with strict abortion laws, some doctors say
Maternal health
Women's healthFacebookTweetLink
Follow
Federal guidance that the Trump administration says is intended to offer clarity is instead leaving health care providers even more confused about whether they can provide an abortion in an emergency, particularly in states with strict abortion laws.
This month, the Trump administration rescinded 2022 federal guidance specifying that under the Emergency Medical Treatment and Labor Act, or EMTALA, people should be able to get an abortion if a medical emergency makes it necessary, even in states with laws that restrict such procedures. HHS and the Centers for Medicare & Medicaid Services said they would continue to enforce the federal law, specifying that the policy included emergency medical conditions that placed the health of a pregnant woman or her unborn child in serious jeopardy.
Then, in a letter to health care providers last week, US Health and Human Services Secretary Robert F. Kennedy Jr. emphasized that under EMTALA, stabilizing care should be given to a person who is pregnant and having a medical emergency – but it doesn't specify what that care might involve.
In the June 13 letter, Kennedy says that it was the 2022 memo that 'created confusion. But that is no more.'
Some doctors beg to differ.
It's unclear exactly what the recision of the previous guidance meant for emergency care, particularly in states with highly restrictive abortion laws, some doctors said. The latest letter doesn't mention abortion at all — and the absence of specifics is creating more uncertainty.
'I do think this just contributes to all of the chaos that clinicians are having to deal with as they just attempt to take care of the patient in front of them and navigate state laws and federal guidance to provide care for patients,' said Dr. Nisha Verma, a practicing obstetrician-gynecologist and senior adviser for reproductive health policy and advocacy at the American College of Obstetricians and Gynecologists, a professional organization that represents the majority of practitioners in the United States. 'It's not something you want to get wrong, because the consequences are so severe and it feels so scary.'
Verma appreciates that the new letter from Kennedy clarifies that EMTALA is still the law of the land, even after the administration rescinded the 2022 guidance. But without a specific mention of abortion, she said, the nation's patchwork of laws makes it difficult for doctors to navigate emergency situations. Some of those state laws could even send doctors to jail if they make the wrong decision about when an emergency necessitates an abortion.
'I think it was helpful to specify abortion is covered under EMTALA' in the 2022 guidance, Verma said. 'I do think that having that language specifically in this really scary, chilling environment was helpful.'
Dr. Alison Haddock, an emergency room doctor who is president of American College of Emergency Physicians, said she was happy that Kennedy's letter confirmed that pregnant patients need access to care and that it included examples of common problems like miscarriages, ectopic pregnancies and premature rupture of membranes.
'Those are some of the situations that have been really challenging for our physicians. Noting that those can represent an obstetric emergency where EMTALA would apply is really good to see,' Haddock said.
But she added that the Trump administration's guidance does not clear up everything.
'I think physicians are still going to have issues with conflicting state law where they are still going to be left in a gray area of uncertainty about how to balance adhering to EMTALA and adhering to state law, and that's going to leave patients in the same place,' Haddock said.
Trips to the emergency room are common for pregnant people, studies show. The majority of emergency providers say they treat pregnant patients in virtually every shift, according to the American College of Obstetricians and Gynecologists, and in some circumstances, treatment to protect a pregnant person's health or life may require an abortion.
Pregnancy emergencies don't always happen during standard work hours, Haddock said, and the 'ability to convene the ethics committee at 2 a.m. is very limited, and then it can be a lot of layers to get through at the hospital.'
Haddock said her association sent a letter to its members encouraging them to advocate for clearer guidance from their own hospitals.
'Achieving greater clarity on this is really important to make sure physicians feel like they have the protections they need to provide lifesaving medical care,' she added.
Specifics have been important when it comes to EMTALA. When it became federal law in 1986, some hospitals refused to care for uninsured women in labor, so in 1989, Congress spelled out that pregnant people who were having contractions had to be given emergency care even if they couldn't pay for it.
In 2021, guidance from the Biden administration added more specifics, saying it was a doctor's duty to provide stabilizing treatment that 'preempts any directly conflicting state law or mandate that might otherwise prohibit or prevent such treatment.'
However, it wasn't until the 2022 guidance that it was spelled out that an abortion had to be provided when necessary.
The Biden administration guidance was meant to eliminate confusion in states with anti-abortion laws that did not include an exception for the life or health of a pregnant person, and it stated that federal law preempted the state statutes in the case of such laws.
That memo was issued just weeks after the US Supreme Court overturned Roe v. Wade, the 1973 ruling that gave pregnant people a constitutional right to an abortion.
A case before the court last year would have clarified whether federal law requires health care services to provide access to emergency care in every state, regardless of abortion laws, but the high court sent it back to the lower courts. In March, the Trump administration dropped the lawsuit. Some legal experts interpreted that as a signal that the administration would not enforce EMTALA.
Even when the 2022 guidance was in place, provider surveys in states that criminalized abortion found that doctors were operating in 'chaos and confusion,' said Payal Shah, director of research, legal and advocacy with the Physicians for Human Rights a Nobel Peace Prize-winning medical and human rights organization. Providers were still having a hard time determining whether EMTALA really would protect them if they had to perform an abortion, even in an emergency situation.
'Criminalization causes fear, and then clinicians feel paralyzed,' Shah said. 'They don't feel like they have the authority to make decisions about reproductive health care in line with their medical judgment and medical ethics and pregnant patients' preferences. Instead, it becomes a legal decision.'
After the Dobbs decision removed the federal right to an abortion in 2022, some women died after doctors told them it would be a 'crime' to intervene in a miscarriage or they couldn't access timely medical care. Idaho's strict abortion law has led some doctors to tell pregnant patients that they should consider buying 'life flight insurance' in case a local hospital wouldn't be able to take care of a pregnancy complication.
Rescinding the 2022 guidance will probably make stories like these more common, several experts said.
'Rescinding this guidance serves no purpose other than to try to strengthen or deepen that confusion,' Shah said. 'This is an attempt to gaslight the American public and to say that criminalization of abortion is working. Criminalization is not working, and that is something the evidence really shows.'
Alexa Kolbi-Molinas, deputy director of the ACLU's Reproductive Freedom Project, interprets the new HHS letter to mean the law does require emergency abortion care, but she added that the administration's actions on the matter 'have been reckless at best and outright dangerous at worst.'
'The Trump administration is scrambling to clean up a mess entirely of its own making,' Kolbi-Molinas said in an email. 'The law has been clear for forty years: pregnant patients who go to a hospital in medical crisis must receive health- and lifesaving care, regardless of state law. If the administration had not rescinded the previous guidance reaffirming hospitals' obligations to provide this care earlier this month, there would have been no need to issue Friday's letter.'
HHS did not respond to direct questions about what 'stabilizing care' meant and whether its interpretation of EMTALA included abortion as stabilizing care. Instead, a spokesperson for the agency sent a link to a June 4 message on X from Dr. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services.
'Don't believe the spin and fearmongering of the fake news,' the post said. 'The Biden Administration created confusion, but EMTALA is clear and the law has not changed: women will receive care for miscarriage, ectopic pregnancy, and medical emergencies in all fifty states- this has not and will never change in the Trump Administration.'
'To me, this question remains: Why won't they use the word 'abortion' if they really believe that abortion is sometimes part of emergency medical care for pregnant people? They won't do it,' said Rebecca Hart Holder, president of Reproductive Equity Now.
'If the Trump administration or Secretary Kennedy truly intended to reassure providers that abortion in the case of a medical emergency, is protected under EMTALA, they would have used those words explicitly as a qualifying example of emergency medical care,' Hart Holder added. 'I think it's a fair assumption to make that even more people are going to die when they're in emergency situations.'
In the wake of Dobbs, the Kennedy letter presents another potential problem, said reproductive law expert Rolonda Donelson.
'In the letter, he mentions that EMTALA requires caring for the pregnant woman and their unborn child. Pre-Dobbs, that might not have meant much, but post-Dobbs, with the rise in fetal personhood in state abortion bans, it raises questions on whether the providers in these emergency departments have any duty to the unborn fetus and whether they can provide this emergency stabilizing care when it conflicts with their state abortion ban,' said Donelson, the Huber Reproductive Health Equity Legal Fellow at the National Partnership for Women & Families.
'This guidance does not provide any clarification. It increases chaos and confusion among patients, providers and everyone on whether they can go into an emergency department if they're experiencing a medical emergency and receive an abortion as necessary stabilizing care.'
In March, concerned that even more clarity was needed, 88 lawmakers reintroduced a resolution that affirmed EMTALA protects access to emergency abortion care. But even if such a bill were to make its way through Congress, it's unclear whether Trump would sign it.
In the absence of additional legislation, legal experts say, the confusion will continue placing an unfair burden on doctors and patients.
'It's unrealistic to have doctors who should be saving patient lives and doing all of those important things to try and also be lawyers and policy advocates and figure out the nitty gritty of what these things mean,' Donelson said.
But it's important for patients to know, she said, that they should go to an emergency room if they are experiencing a medical emergency.
'The last thing I would want is a pregant person who is experiencing a medical emergency to think that they won't be able to get care at a hospital and forgo going and then something bad happen to them.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
Eli Lilly accused of bribing providers to prescribe GLP-1RA drugs
Despite posting record Q2 growth for its blockbuster weight loss and diabetes drug tirzepatide, Eli Lilly is facing legal challenge from a lawsuit filed in Texas that accuses the pharma company of bribing providers to prescribe its drugs. Attorney General for Texas Ken Paxton and Health Choice Alliance claim Eli Lilly 'offered illegal incentives' to medical providers in the southern state so its most profitable drugs, including popular glucagon-like peptide-1 receptor agonist (GLP-1RA) medications tirzepatide, marketed as Mounjaro and Zepbound, would be preferentially prescribed to patients. The lawsuit marks the latest legal assault by the attorney general's office, having previously sued Eli Lilly over an industry conspiracy to increase insulin prices. Health Choice Alliance has also filed previous legal action against Eli Lilly in the past. In the latest filing, Paxton and Health Choice Alliance claim that Eli Lilly's actions cost Texas Medicaid 'millions of dollars'. The claimants argue that prescriptions were covered by the government insurance programme, resulting in claims to Texas Medicaid that were 'tainted by Eli Lilly's illegal marketing and quid pro quo arrangements'. As per the filing, Lilly is alleged to have participated in two schemes to induce and influence providers. In the first, the pharma company, with the help of third parties, apparently provided free nursing services. The second scheme alleges that Lilly continues to offer reimbursement support services to get their drugs prescribed over rivals. An Eli Lilly spokesperson told Pharmaceutical Technology that it intends to 'vigorously defend against these allegations'. The spokesperson added: 'Multiple courts and the federal government have rejected claims by this same corporate relator against Lilly as meritless. In fact, the United States Government determined that 'the relators' allegations lack sufficient factual and legal support' in a prior case, explaining that federal healthcare programs have a strong interest in ensuring that, after a physician has appropriately prescribed a medication, patients have access to basic product support relating to their medication." This referred to similar kickback claims previously made by Health Choice Alliance. Lilly was originally sued by the organisation in 2017, alleged to have participated in a 'multi-tiered kickback scheme' along with other pharma companies, including Bayer. This involved offering free nursing services in exchange for preferential drug prescriptions. The case was dismissed a year later by a judge in Texas. In 2021, a court of appeals upheld the prior decision to scrap the case amid attempts to revive the lawsuit. It is also not the first time the state of Texas has accused Lilly of unlawful activities. In October 2024, the attorney general's office sued several drugmakers and pharmacy benefit managers (PBMs) over insulin product prices. According to a statement at the time, Paxton accused manufacturers of a 'conspiracy' to artificially and willingly raise insulin prices and then pay an undisclosed amount back to PBMs in a quid pro quo arrangement. Lilly had a strong Q2 as it extended its lead over rival Novo Nordisk in the GLP-1RA treatment space. The company reported growth of 172% and 68% for Zepbound and Mounjaro, respectively. The two drugs brought in combined sales of $8.57bn in the quarter. "Eli Lilly accused of bribing providers to prescribe GLP-1RA drugs" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
a minute ago
- Yahoo
AN Supps Expands Innovation With Iconic Chiquita® Brand Collab and a Nationwide Walmart U.S. Launch
NASHVILLE, Tenn., August 13, 2025--(BUSINESS WIRE)--With the indulgence of beach barbeques and happy hours fading into rear view mirrors, consumers will stock up on health and wellness related foods and beverages, while shopping for the Fall. AN Supps, a division of Applied Nutrition PLC, has responded to this trend - joining forces with Chiquita® Brands International and thousands of Walmart U.S. stores to deliver protein and pre-workout sports beverage mixes. AN Supps began its partnership with Chiquita® earlier in 2025, with five co-branded sports nutrition products exclusively sold through The Vitamin Shoppe. The expanded partnership through Walmart allows shoppers to enjoy not only nutritious, healthy supplements so simple to use – but also a great-tasting source for beverage and food snacks, suited for many lifestyles. The AN ESSENTIAL line of Chiquita® co-branded sports nutrition powders, exclusively from AN Supps, is now available at thousands of Walmart locations in the United States, and on "This partnership evolved naturally," remarked Aaron Heidebreicht, CEO of AN Supps. "Bananas are the world's most popular fruit. Walmart already sells over three billion bananas annually in the United States alone. We are determined to address unmet demand in our own aisles. The Chiquita® banner helps us to reinforce the integrity and quality of our sports nutrition, as Chiquita does with its core product." Heidebreicht continued. "Each offering delivers on natural flavors – and a serving of each protein powder has 100% of the potassium found in a banana. We are giving wellness consumers the solution they need elsewhere in a Walmart location. Plus, the protein product, like any Chiquita® banana, tastes delicious." Walmart will be offering two protein powders from AN Supps, featuring the Chiquita co-branding – a banana chocolate whey protein, and a banana strawberry whey protein. Both are gluten-free, potassium enriched, and servings from each contain 20 grams of protein. AN Supps will further celebrate the bevy of fresh fruit that also define the Chiquita® brand equity. Chiquita® distributes fresh apples, berries, pineapples, grapes, melon and citrus worldwide. These inspire two additional Chiquita® co-branded items at Walmarts nationwide: pineapple strawberry and fruit blend pre-workout powders. Much like the Chiquita® fruits inspiring these powders, both are gluten-free, soy-free, vegan-friendly, and with no added sugar. "Chiquita® has been meticulous in its approach to extending across aisles at retail chains as prestigious as Walmart," said Maria Janis, Vice-President, Licensing at Chiquita® Brands International. "We ask ourselves introspectively: Does the new category complement wholesome nutrition? Will it appeal to a wide demographic? Do the ingredient and flavor profiles align with Chiquita® fresh produce we ship worldwide? Does the new category reinforce our brand's wellness values? And importantly, will the product meet the needs of critical stakeholders – our shoppers and the retail chains they frequent? The AN Supps line, quite simply, checks all the boxes," Janis remarked. "Applied Nutrition PLC is a public company traded on the London Stock Exchange," continued Heidebreicht. "Our stockholders mandate us to innovate and surpass consumer expectations, while paying homage to the trademark brands that long achieved those goals. We benefit in multiple ways through our strategic alliance with Chiquita® Brands International, and with Walmart locations throughout the United States. This extends our global alliance with these partners, which consumers everywhere continue to enjoy," Heidebreicht said. The four AN Supps SKUs at Walmart U.S. locations, co-branded with Chiquita®, include banana-chocolate whey protein; banana-strawberry whey protein; pineapple-strawberry pre-workout powder; and fruit blend pre-workout powder. About Chiquita® Brands International Chiquita® is a leading global produce company that is committed to providing both consumers and customers across nearly 70 countries with the highest quality of fruit and service, making Chiquita® the banana of choice. For more than 150 years, Chiquita® has been proudly producing great-tasting, superior quality bananas. The brand creates a positive impact by implementing the principles of sustainability throughout all of its business practices under the "Behind the Blue Sticker" initiative. The iconic Blue Sticker has been the seal of approval for high-quality fruit, and a celebration of fun, but it also represents an unwavering commitment to sustainable farming, biodiversity and giving back to the communities in which the banana plantations operate. Great-tasting and convenient Chiquita® bananas are fat-free, and provide a source of potassium, fiber and vitamin B6. To learn more, visit About Applied Nutrition PLC Applied Nutrition PLC, is a leading sports nutrition, health and wellness brand, which formulates and creates nutrition products targeted at a wide range of consumers and sold in over 80 countries worldwide. Its vision is to be the world's most trusted and innovative sports nutrition, health & wellness brand. The values at Applied Nutrition reflect our passion for health, wellbeing and integrity. Applied Nutrition PLC, and its North American division, AN Supps, are committed to excellence, fostering a positive and supportive environment for both its team and its customers. By maintaining the highest standards, Applied Nutrition PLC ensures that every product and service we provide reflects our passion for health, integrity, and innovation. On 29 October, 2024, Applied Nutrition PLC was admitted to the London Stock Exchange. To learn more, visit and View source version on Contacts Alma Strategic Communications Rebecca Sanders-Hewett, Josh Royston, Sam Modlin, Joe Pederzolli, Sarah PetersT: +44 (0) 203 405 0205appliednutrition@ 登入存取你的投資組合
Yahoo
a minute ago
- Yahoo
These jobs are hiring, despite a weak job market
The labor market slowed sharply this summer, leaving job applicants with fewer places to turn for a new position. Employers added an average of about 35,000 jobs over three months ending in July, which marks a major slowdown from roughly 128,000 jobs added monthly over the prior three months, the U.S. Bureau of Labor Statistics said earlier this month. The hiring cooldown has hit nearly every industry, including manufacturing, leisure and hospitality and the federal government. But two industries have bucked the trend: Health care and social assistance, the latter of which comprises services like child care and counseling, economists told ABC News. If not for job growth in those two sectors, the labor market would have suffered net job losses over the past three months. MORE: Trump admin live updates: Trump and Putin to meet at Joint Base Elmendorf-Richardson "This is a job market where growth is very thin," Daniel Zhao, chief economist at job-posting site Glassdoor, told ABC News. "Unfortunately, there aren't many industries growing consistently and robustly." "The job market is being propped up by health care and social assistance," Zhao added. Health care The health care sector added 55,000 jobs in July, which amounted to three of every four jobs added across the U.S. economy last month, BLS data showed. The performance in July extended robust growth that stretches back several years, economists said. "There's clearly an industry that stands out right now and that would be health care," Cory Stahle, an economist at Indeed Hiring Lab, told ABC News. The gangbusters hiring in the health care sector owes to two overlapping trends, economists said: persistent demand for health care from an aging population and ongoing recovery from job losses during the COVID-19 pandemic. Unlike discretionary costs like luxury goods or restaurant dining, health care services are a necessity taken up by consumers regardless of financial conditions, economists said. "Health care is a non-optional industry," Stahle said. "If you need health care, you need health care." As the baby-boomer generation has aged, a growing share of people have experienced such healthcare needs. Between 2012 and 2050, the population of older people – aged 65 and above – is expected to nearly double from about 43 million to 83 million, the U.S. Census Bureau found in 2014. Robust consumer demand has coincided with a shortage of workers in the aftermath of widespread job losses as health care professionals suffered burnout during the COVID-19 pandemic. While overall employment in the sector has recovered to pre-pandemic levels, the new workers have been unevenly distributed, leaving shortages at workplaces such as skilled nursing facilities and intensive behavioral health centers, researchers at the University of Michigan found in June. "We do expect job growth in health care to continue as the U.S. population ages and demand for health services continues to rise," Zhao said. Social assistance Social assistance, the provision of support and emergency relief services, makes up the other bright spot in the job market. The sector added 18,000 jobs in July, accounting for nearly one of every four jobs added last month, BLS data showed. A subset of the sector, referred to by the descriptor "individual and family services," accounted for all of the jobs added in July. Such work is made up of counseling, welfare and referral services. MORE: Who is E.J. Antoni, Trump's pick to lead the BLS? Employers have continued to hire for therapist roles, despite a slowdown in the wider job market, Stahle said, citing job postings on Indeed. If the economy tips into a recession, the industry will likely continue to grow, since a larger share of the population would need assistance in the event of financial hardship, Zhao said. "This is a sector that grows even during bad times, because there is a demand for more social assistance when the economy is poor and people do need those services," Zhao added. Positions in the sector are not typically well compensated, however. Average hourly earnings in social assistance clocked in at $23.60 in June, the most recent month for which such data is available. That pay level came in well below an average of $36.32 per hour across the private sector, BLS data showed.